Articles by Disease (Sarcoma)

Mast Cells as Target in Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 15
Page: 1868-1878
Author(s): Tom Groot Kormelink, Abulikemu Abudukelimu and Frank A. Redegeld

Regulatory T Cells: Major Players in the Tumor Microenvironment

Journal: Current Pharmaceutical Design
Volume: 15
Page: 1879-1892
Author(s): Marc Beyer and Joachim L. Schultze

HtrA Serine Proteases as Potential Therapeutic Targets in Cancer

Journal: Current Cancer Drug Targets
Volume: 9
Page: 451-468
Author(s): Jeremy Chien, Mara Campioni, Viji Shridhar and Alfonso Baldi

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9
Page: 113-131
Author(s): Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti

Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9
Page: 151-177
Author(s): S. Rutella, G. Bonanno and R. De Cristofaro

A Unique Mechanism of Chaperone Action: Heme Regulation of Hap1 Activity Involves Separate Control of Repression and Activation

Journal: Protein & Peptide Letters
Volume: 16
Page: 642-649
Author(s): Hee Chul Lee and Li Zhang

Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 9
Page: 90-105
Author(s): Mohamed Labib Salem, Faris Q. Alenzi, Narender Nath, Sabry A. El-Naggar, Amir A. Al-Khami, Ali A. Al-Jabri, Jamal Arif, Iman M. El-Nashar, Iman El-Tounsi and Richard K.H. Wyse